Oncolytics Biotech Inc.

ONCY · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$15,942$34,912$11,666$41,262
Short-Term Investments$0$0$20,472$0
Receivables$68$15$521$866
Inventory$0$0$0$0
Other Curr. Assets$2,865$3,246$3,025$2,776
Total Curr. Assets$18,875$38,173$35,684$44,904
Property Plant & Equip (Net)$1,312$647$652$976
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$0$0$998$0
Total NC Assets$1,312$647$1,650$976
Other Assets$0$0$0$0
Total Assets$20,187$38,820$37,334$45,880
Liabilities
Payables$1,087$1,082$2,252$594
Short-Term Debt$277$133$216$294
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$5,323$3,022$1,477$1,802
Total Curr. Liab.$6,687$4,237$3,945$2,690
LT Debt$787$290$157$361
Deferred Rev, NC$6,730$6,730$6,730$6,730
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$7,517$7,020$6,887$7,091
Other Liabilities$0$0$0$0
Cap. Leases$1,064$423$373$655
Total Liabilities$14,204$11,257$10,832$9,781
Equity
Pref Stock$0$0$0$0
Common Stock$438,193$430,906$404,040$391,348
Retained Earnings-$477,713-$446,003-$418,251-$393,416
AOCI$961$544$662$388
Other Equity$44,542$42,116$40,051$37,779
Total Equity$5,983$27,563$26,502$36,099
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$20,187$38,820$37,334$45,880
Net Debt-$14,878-$34,489-$11,293-$40,607